Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: The characteristics and clinical relevance of tumor fusion burden in non-EBV (+) gastric cancer with MSS

Fig. 3

Tumor immune activity of patients with high or low TFB in the MSS and non-EBV (+) cohort. (A and B) The abundance of 28 immune cell subpopulations in the TGCA GC cohort and the 45-case cohort from ENA (PRJEB25780). Data were analyzed by Wilcoxon test. Significant differences: *p < 0.05, **p < 0.01, and ***p < 0.001. No significant difference is indicated as ns. (C) The immune gene signature. Data were analyzed by Wilcox test. *p < 0.05

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us